Log In
BCIQ
Print this Print this
 

ACTX01

  Manage Alerts
Collapse Summary General Information
Company Avrygen Corp.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today